Travere Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Travere Therapeutics shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Travere Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Travere Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Travere Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $634k | 556k | 1.14 |
| 2025-03-31 | $903k | 871k | 1.04 |
| 2024-12-31 | $860k | 900k | 0.96 |
| 2024-09-30 | $777k | 900k | 0.86 |
| 2023-12-31 | $81k | 125k | 0.65 |
| 2023-09-30 | $81k | 125k | 0.65 |
| 2023-06-30 | $102k | 125k | 0.81 |
| 2023-03-31 | $123k | 125k | 0.98 |